Skip to content

Categories: pharmacovigilance

  • NNIT’s Marina Prodan selected as Talent 100

    NNIT’s Marina Prodan selected as Talent 100

    More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.

  • Valiance – An NNIT Group Company

    Valiance – An NNIT Group Company

    NNIT has evolved quite dramatically over the years, from a small independent IT consultancy born out of Novo Nordisk to a publicly listed company and now an international group of companies in its own right. This article is the second in a series looking at the individual NNIT Group Companies.

  • Lægemidler skal være sikre

    Lægemidler skal være sikre

    Vi bad Jesper Borgstrøm, Advanced Advisory Consultant, i NNIT Life Sciences – Regulatory Affairs, om at guide os gennem de sikkerhedsprocedurer, der gælder for en af verdens mest regulerede produktudviklings og -produktionsprocesser.

  • The importance of ensuring drug safety

    The importance of ensuring drug safety

    We asked Jesper Borgstrøm, Advanced Advisory Consultant, NNIT Life Sciences – Regulatory Affairs, to take us through the safety aspects of one of the world’s most regulated product development and manufacturing processes.

  • ISO IDMP is the next after xEVMPD

    ISO IDMP is the next wave in the pharmacovigilance legislation after xEVMPD. But with a global scope and requiring data integration from the entire company it is a much bigger wave. ISO IDMP will transform your regulatory IT strategy.

  • PSMF establishment and maintenance, business as usual?

    Since the implementation of Directive 2010/84 and Regulation 1235/2010, marketing authorisation holders (MAHs) with products on the European market are obliged to maintain, and make available upon request, a Pharmacovigilance System Master File (PSMF).